Annual Gross Profit
$34.31 B
-$1.71 B-4.74%
31 December 2023
Summary:
Bristol-Myers Squibb annual gross profit is currently $34.31 billion, with the most recent change of -$1.71 billion (-4.74%) on 31 December 2023. During the last 3 years, it has risen by +$3.57 billion (+11.61%). BMY annual gross profit is now -5.85% below its all-time high of $36.45 billion, reached on 31 December 2021.BMY Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$8.94 B
+$1.00 M+0.01%
30 September 2024
Summary:
Bristol-Myers Squibb quarterly gross profit is currently $8.94 billion, with the most recent change of +$1.00 million (+0.01%) on 30 September 2024. Over the past year, it has increased by +$475.00 million (+5.61%). BMY quarterly gross profit is now -7.21% below its all-time high of $9.63 billion, reached on 31 December 2021.BMY Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$35.53 B
+$475.00 M+1.35%
30 September 2024
Summary:
Bristol-Myers Squibb TTM gross profit is currently $35.53 billion, with the most recent change of +$475.00 million (+1.35%) on 30 September 2024. Over the past year, it has increased by +$1.14 billion (+3.31%). BMY TTM gross profit is now -4.96% below its all-time high of $37.39 billion, reached on 31 March 2022.BMY TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMY Gross Profit Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -4.7% | +5.6% | +3.3% |
3 y3 years | +11.6% | -4.3% | +1.6% |
5 y5 years | +113.2% | +111.9% | +109.3% |
BMY Gross Profit High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -5.8% | +11.6% | -7.2% | +7.0% | -5.0% | +3.6% |
5 y | 5 years | -5.8% | +113.2% | -7.2% | +111.9% | -5.0% | +109.3% |
alltime | all time | -5.8% | +533.4% | -7.2% | +502.5% | -5.0% | +1852.4% |
Bristol-Myers Squibb Gross Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $8.94 B(+0.0%) | $35.53 B(+1.4%) |
June 2024 | - | $8.93 B(+0.0%) | $35.06 B(+1.7%) |
Mar 2024 | - | $8.93 B(+2.3%) | $34.48 B(+0.5%) |
Dec 2023 | $34.31 B(-4.7%) | $8.73 B(+3.2%) | $34.31 B(-0.2%) |
Sept 2023 | - | $8.46 B(+1.3%) | $34.39 B(-1.2%) |
June 2023 | - | $8.35 B(-4.8%) | $34.80 B(-2.3%) |
Mar 2023 | - | $8.77 B(-0.5%) | $35.62 B(-1.1%) |
Dec 2022 | $36.02 B(-1.2%) | $8.81 B(-0.6%) | $36.02 B(-2.2%) |
Sept 2022 | - | $8.87 B(-3.3%) | $36.84 B(-1.3%) |
June 2022 | - | $9.17 B(-0.1%) | $37.31 B(-0.2%) |
Mar 2022 | - | $9.18 B(-4.7%) | $37.39 B(+2.6%) |
Dec 2021 | $36.45 B(+18.5%) | $9.63 B(+3.2%) | $36.45 B(+4.2%) |
Sept 2021 | - | $9.33 B(+0.9%) | $34.97 B(+3.8%) |
June 2021 | - | $9.25 B(+12.4%) | $33.68 B(+5.7%) |
Mar 2021 | - | $8.23 B(+0.9%) | $31.86 B(+3.6%) |
Dec 2020 | $30.75 B(+70.2%) | $8.16 B(+1.5%) | $30.75 B(+9.6%) |
Sept 2020 | - | $8.04 B(+8.2%) | $28.04 B(+15.8%) |
June 2020 | - | $7.43 B(+4.4%) | $24.22 B(+14.8%) |
Mar 2020 | - | $7.12 B(+30.6%) | $21.09 B(+16.7%) |
Dec 2019 | $18.07 B(+12.3%) | $5.45 B(+29.3%) | $18.07 B(+6.4%) |
Sept 2019 | - | $4.22 B(-2.0%) | $16.98 B(+1.0%) |
June 2019 | - | $4.30 B(+5.0%) | $16.80 B(+1.3%) |
Mar 2019 | - | $4.10 B(-6.1%) | $16.58 B(+3.0%) |
Dec 2018 | $16.09 B(+9.0%) | $4.36 B(+7.9%) | $16.09 B(+3.3%) |
Sept 2018 | - | $4.04 B(-0.9%) | $15.58 B(+2.4%) |
June 2018 | - | $4.08 B(+13.0%) | $15.21 B(+3.4%) |
Mar 2018 | - | $3.61 B(-6.2%) | $14.71 B(-0.4%) |
Dec 2017 | $14.76 B(+2.1%) | $3.85 B(+4.7%) | $14.76 B(+0.1%) |
Sept 2017 | - | $3.67 B(+2.8%) | $14.75 B(+0.4%) |
June 2017 | - | $3.58 B(-2.4%) | $14.69 B(-0.6%) |
Mar 2017 | - | $3.66 B(-4.5%) | $14.78 B(+2.2%) |
Dec 2016 | $14.46 B(+14.3%) | $3.84 B(+6.1%) | $14.46 B(+3.6%) |
Sept 2016 | - | $3.62 B(-1.3%) | $13.96 B(+4.8%) |
June 2016 | - | $3.67 B(+9.8%) | $13.31 B(+4.0%) |
Mar 2016 | - | $3.34 B(+0.1%) | $12.80 B(+1.1%) |
Dec 2015 | $12.65 B(+5.9%) | $3.33 B(+12.2%) | $12.65 B(+0.3%) |
Sept 2015 | - | $2.97 B(-5.7%) | $12.61 B(+0.5%) |
June 2015 | - | $3.15 B(-1.4%) | $12.55 B(+2.0%) |
Mar 2015 | - | $3.19 B(-3.0%) | $12.30 B(+2.9%) |
Dec 2014 | $11.95 B(+1.5%) | $3.29 B(+13.0%) | $11.95 B(+1.0%) |
Sept 2014 | - | $2.91 B(+0.6%) | $11.82 B(+0.2%) |
June 2014 | - | $2.90 B(+1.9%) | $11.80 B(-0.4%) |
Mar 2014 | - | $2.84 B(-10.3%) | $11.84 B(+0.6%) |
Dec 2013 | $11.77 B(-9.6%) | $3.17 B(+9.6%) | $11.77 B(+0.4%) |
Sept 2013 | - | $2.89 B(-1.7%) | $11.71 B(+1.2%) |
June 2013 | - | $2.94 B(+6.2%) | $11.57 B(-2.2%) |
Mar 2013 | - | $2.77 B(-11.2%) | $11.83 B(-9.1%) |
Dec 2012 | $13.01 B(-16.8%) | $3.12 B(+13.4%) | $13.01 B(-6.9%) |
Sept 2012 | - | $2.75 B(-14.0%) | $13.98 B(-7.8%) |
June 2012 | - | $3.20 B(-19.0%) | $15.17 B(-4.7%) |
Mar 2012 | - | $3.95 B(-3.4%) | $15.93 B(+1.8%) |
Dec 2011 | $15.65 B(+10.1%) | $4.09 B(+3.8%) | $15.65 B(+2.6%) |
Sept 2011 | - | $3.94 B(-0.4%) | $15.26 B(+2.8%) |
June 2011 | - | $3.95 B(+7.8%) | $14.84 B(+3.2%) |
Mar 2011 | - | $3.67 B(-0.8%) | $14.37 B(+1.2%) |
Dec 2010 | $14.21 B(+3.9%) | $3.70 B(+5.1%) | $14.21 B(+0.7%) |
Sept 2010 | - | $3.52 B(+0.8%) | $14.11 B(+0.3%) |
June 2010 | - | $3.49 B(-0.3%) | $14.06 B(+0.4%) |
Mar 2010 | - | $3.50 B(-2.8%) | $14.01 B(+2.5%) |
Dec 2009 | $13.67 B(+10.2%) | $3.60 B(+3.7%) | $13.67 B(+14.0%) |
Sept 2009 | - | $3.47 B(+0.9%) | $11.99 B(-1.2%) |
June 2009 | - | $3.44 B(+9.0%) | $12.14 B(-0.8%) |
Mar 2009 | - | $3.16 B(+64.0%) | $12.23 B(-1.3%) |
Dec 2008 | $12.40 B(-5.6%) | $1.93 B(-46.8%) | $12.40 B(-15.2%) |
Sept 2008 | - | $3.62 B(+2.5%) | $14.62 B(+3.5%) |
June 2008 | - | $3.53 B(+6.4%) | $14.12 B(+3.4%) |
Mar 2008 | - | $3.32 B(-19.9%) | $13.65 B(+2.6%) |
Dec 2007 | $13.13 B(+14.0%) | $4.15 B(+32.8%) | $13.31 B(+15.9%) |
Sept 2007 | - | $3.12 B(+2.0%) | $11.49 B(+3.9%) |
June 2007 | - | $3.06 B(+2.9%) | $11.05 B(-2.1%) |
Mar 2007 | - | $2.98 B(+28.0%) | $11.29 B(-1.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2006 | $11.52 B(-10.5%) | $2.33 B(-13.5%) | $11.52 B(-5.6%) |
Sept 2006 | - | $2.69 B(-18.6%) | $12.21 B(-4.6%) |
June 2006 | - | $3.30 B(+3.2%) | $12.80 B(-0.8%) |
Mar 2006 | - | $3.20 B(+6.2%) | $12.90 B(+0.3%) |
Dec 2005 | $12.87 B(-3.9%) | $3.01 B(-8.3%) | $12.87 B(-3.6%) |
Sept 2005 | - | $3.28 B(-3.6%) | $13.35 B(-0.2%) |
June 2005 | - | $3.41 B(+7.6%) | $13.37 B(+0.7%) |
Mar 2005 | - | $3.17 B(-9.4%) | $13.29 B(-0.8%) |
Dec 2004 | $13.39 B(+1.1%) | $3.49 B(+5.5%) | $13.39 B(-0.1%) |
Sept 2004 | - | $3.31 B(-0.2%) | $13.41 B(-1.0%) |
June 2004 | - | $3.32 B(+1.5%) | $13.54 B(+0.3%) |
Mar 2004 | - | $3.27 B(-6.8%) | $13.50 B(+1.9%) |
Dec 2003 | $13.25 B(+14.5%) | $3.51 B(+1.9%) | $13.25 B(+5.1%) |
Sept 2003 | - | $3.44 B(+5.1%) | $12.61 B(+4.6%) |
June 2003 | - | $3.28 B(+8.5%) | $12.05 B(+5.4%) |
Mar 2003 | - | $3.02 B(+5.2%) | $11.43 B(-1.2%) |
Dec 2002 | $11.57 B(-7.7%) | $2.87 B(-0.4%) | $11.57 B(-1.1%) |
Sept 2002 | - | $2.88 B(+8.3%) | $11.71 B(-2.5%) |
June 2002 | - | $2.66 B(-15.8%) | $12.01 B(-5.5%) |
Mar 2002 | - | $3.16 B(+5.1%) | $12.71 B(-1.9%) |
Dec 2001 | $12.53 B(-6.9%) | $3.00 B(-5.6%) | $12.96 B(+0.5%) |
Sept 2001 | - | $3.18 B(-5.3%) | $12.89 B(-2.8%) |
June 2001 | - | $3.36 B(-1.3%) | $13.25 B(-5.1%) |
Mar 2001 | - | $3.41 B(+16.0%) | $13.97 B(-0.6%) |
Dec 2000 | $13.46 B(+3.4%) | $2.94 B(-17.3%) | $14.06 B(-4.2%) |
Sept 2000 | - | $3.55 B(-12.9%) | $14.68 B(+2.5%) |
June 2000 | - | $4.08 B(+16.5%) | $14.32 B(+2.5%) |
Mar 2000 | - | $3.50 B(-1.7%) | $13.97 B(-1.5%) |
Dec 1999 | $13.01 B(+10.4%) | $3.56 B(+11.5%) | $14.19 B(+17.1%) |
Sept 1999 | - | $3.19 B(-14.2%) | $12.12 B(-2.4%) |
June 1999 | - | $3.72 B(+0.2%) | $12.41 B(+2.9%) |
Mar 1999 | - | $3.72 B(+150.6%) | $12.06 B(+2.3%) |
Dec 1998 | $11.79 B(-8.1%) | $1.48 B(-57.5%) | $11.79 B(-14.3%) |
Sept 1998 | - | $3.49 B(+3.5%) | $13.75 B(+2.3%) |
June 1998 | - | $3.37 B(-2.3%) | $13.44 B(+2.0%) |
Mar 1998 | - | $3.45 B(+0.1%) | $13.18 B(+2.7%) |
Dec 1997 | $12.83 B(+10.4%) | $3.44 B(+8.3%) | $12.83 B(+3.4%) |
Sept 1997 | - | $3.18 B(+2.5%) | $12.41 B(+2.6%) |
June 1997 | - | $3.10 B(+0.0%) | $12.10 B(+2.1%) |
Mar 1997 | - | $3.10 B(+2.4%) | $11.85 B(+2.0%) |
Dec 1996 | $11.62 B(+9.8%) | $3.03 B(+5.6%) | $11.62 B(+1.3%) |
Sept 1996 | - | $2.87 B(+0.4%) | $11.47 B(+2.7%) |
June 1996 | - | $2.86 B(-0.3%) | $11.17 B(+2.1%) |
Mar 1996 | - | $2.87 B(-0.4%) | $10.93 B(+3.4%) |
Dec 1995 | $10.58 B(+15.1%) | $2.88 B(+11.9%) | $10.58 B(+4.1%) |
Sept 1995 | - | $2.57 B(-2.0%) | $10.16 B(+3.2%) |
June 1995 | - | $2.62 B(+4.5%) | $9.84 B(+3.3%) |
Mar 1995 | - | $2.51 B(+2.1%) | $9.53 B(+3.7%) |
Dec 1994 | $9.19 B(+5.7%) | $2.46 B(+9.1%) | $9.19 B(+2.2%) |
Sept 1994 | - | $2.25 B(-2.3%) | $8.99 B(+0.9%) |
June 1994 | - | $2.31 B(+6.4%) | $8.91 B(+1.7%) |
Mar 1994 | - | $2.17 B(-4.2%) | $8.77 B(+0.9%) |
Dec 1993 | $8.69 B(+1.1%) | $2.26 B(+4.0%) | $8.69 B(+4.5%) |
Sept 1993 | - | $2.17 B(+0.6%) | $8.32 B(-2.1%) |
June 1993 | - | $2.16 B(+3.5%) | $8.50 B(-0.5%) |
Mar 1993 | - | $2.09 B(+10.5%) | $8.54 B(-0.6%) |
Dec 1992 | $8.59 B(+1.4%) | $1.89 B(-19.7%) | $8.59 B(-3.8%) |
Sept 1992 | - | $2.35 B(+6.9%) | $8.93 B(+2.8%) |
June 1992 | - | $2.20 B(+2.8%) | $8.69 B(+1.6%) |
Mar 1992 | - | $2.14 B(-3.8%) | $8.55 B(+0.9%) |
Dec 1991 | $8.47 B(+10.5%) | $2.23 B(+5.7%) | $8.47 B(+2.3%) |
Sept 1991 | - | $2.11 B(+1.9%) | $8.29 B(+1.8%) |
June 1991 | - | $2.07 B(+0.1%) | $8.14 B(+2.8%) |
Mar 1991 | - | $2.07 B(+1.3%) | $7.92 B(+3.2%) |
Dec 1990 | $7.67 B(+14.0%) | $2.04 B(+4.0%) | $7.67 B(+36.2%) |
Sept 1990 | - | $1.96 B(+6.2%) | $5.63 B(+53.5%) |
June 1990 | - | $1.85 B(+1.5%) | $3.67 B(+101.5%) |
Mar 1990 | - | $1.82 B | $1.82 B |
Dec 1989 | $6.73 B(+7.5%) | - | - |
Dec 1988 | $6.26 B(+15.5%) | - | - |
Dec 1987 | $5.42 B | - | - |
FAQ
- What is Bristol-Myers Squibb annual gross profit?
- What is the all time high annual gross profit for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb annual gross profit year-on-year change?
- What is Bristol-Myers Squibb quarterly gross profit?
- What is the all time high quarterly gross profit for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly gross profit year-on-year change?
- What is Bristol-Myers Squibb TTM gross profit?
- What is the all time high TTM gross profit for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb TTM gross profit year-on-year change?
What is Bristol-Myers Squibb annual gross profit?
The current annual gross profit of BMY is $34.31 B
What is the all time high annual gross profit for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual gross profit is $36.45 B
What is Bristol-Myers Squibb annual gross profit year-on-year change?
Over the past year, BMY annual gross profit has changed by -$1.71 B (-4.74%)
What is Bristol-Myers Squibb quarterly gross profit?
The current quarterly gross profit of BMY is $8.94 B
What is the all time high quarterly gross profit for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly gross profit is $9.63 B
What is Bristol-Myers Squibb quarterly gross profit year-on-year change?
Over the past year, BMY quarterly gross profit has changed by +$475.00 M (+5.61%)
What is Bristol-Myers Squibb TTM gross profit?
The current TTM gross profit of BMY is $35.53 B
What is the all time high TTM gross profit for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high TTM gross profit is $37.39 B
What is Bristol-Myers Squibb TTM gross profit year-on-year change?
Over the past year, BMY TTM gross profit has changed by +$1.14 B (+3.31%)